These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26202986)

  • 1. γ-Tilmanocept, a New Radiopharmaceutical Tracer for Cancer Sentinel Lymph Nodes, Binds to the Mannose Receptor (CD206).
    Azad AK; Rajaram MV; Metz WL; Cope FO; Blue MS; Vera DR; Schlesinger LS
    J Immunol; 2015 Sep; 195(5):2019-29. PubMed ID: 26202986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cy3-tilmanocept labeling of macrophages in joints of mice with antibody-induced arthritis and synovium of human patients with rheumatoid arthritis.
    Toribio RE; Young N; Schlesinger LS; Cope FO; Ralph DA; Jarjour W; Rosol TJ
    J Orthop Res; 2021 Apr; 39(4):821-830. PubMed ID: 33107629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of melanoma, breast cancer and head and neck squamous cell cancer sentinel lymph nodes by Tc-99m Tilmanocept (Lymphoseek®).
    Leong SP
    Clin Exp Metastasis; 2022 Feb; 39(1):39-50. PubMed ID: 34962630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Imaging of the Glomerulus via Mesangial Cell Uptake of Radiolabeled Tilmanocept.
    Qin Z; Hoh CK; Olson ES; Jahromi AH; Hall DJ; Barback CV; You YH; Yanagita M; Sharma K; Vera DR
    J Nucl Med; 2019 Sep; 60(9):1325-1332. PubMed ID: 30796169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [99mTc]Tilmanocept Lymphscintigraphy after inconclusive [99mTc]Nanocolloid Scan in Breast Cancer.
    Kircher M; Seifert S; Kircher S; Lapa C
    Nuklearmedizin; 2019 Jun; 58(3):282-284. PubMed ID: 31064028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined analysis of phase III trials evaluating [⁹⁹mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma.
    Sondak VK; King DW; Zager JS; Schneebaum S; Kim J; Leong SP; Faries MB; Averbook BJ; Martinez SR; Puleo CA; Messina JL; Christman L; Wallace AM
    Ann Surg Oncol; 2013 Feb; 20(2):680-8. PubMed ID: 23054107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a novel receptor-targeted (CD206) radiotracer, 99mTc-tilmanocept, and SPECT/CT for sentinel lymph node detection in oral cavity squamous cell carcinoma: initial institutional report in an ongoing phase 3 study.
    Marcinow AM; Hall N; Byrum E; Teknos TN; Old MO; Agrawal A
    JAMA Otolaryngol Head Neck Surg; 2013 Sep; 139(9):895-902. PubMed ID: 24051744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase 2 study of (99m)Tc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer.
    Leong SP; Kim J; Ross M; Faries M; Scoggins CR; Metz WL; Cope FO; Orahood RC
    Ann Surg Oncol; 2011 Apr; 18(4):961-9. PubMed ID: 21331809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials.
    Wallace AM; Han LK; Povoski SP; Deck K; Schneebaum S; Hall NC; Hoh CK; Limmer KK; Krontiras H; Frazier TG; Cox C; Avisar E; Faries M; King DW; Christman L; Vera DR
    Ann Surg Oncol; 2013 Aug; 20(8):2590-9. PubMed ID: 23504141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [(99m)Tc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional Trial.
    Agrawal A; Civantos FJ; Brumund KT; Chepeha DB; Hall NC; Carroll WR; Smith RB; Zitsch RP; Lee WT; Shnayder Y; Cognetti DM; Pitman KT; King DW; Christman LA; Lai SY
    Ann Surg Oncol; 2015 Oct; 22(11):3708-15. PubMed ID: 25670018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of a Novel CD206+ Macrophage-Specific Arterial Imaging Strategy in HIV-Infected Individuals.
    Zanni MV; Toribio M; Wilks MQ; Lu MT; Burdo TH; Walker J; Autissier P; Foldyna B; Stone L; Martin A; Cope F; Abbruzzese B; Brady T; Hoffmann U; Williams KC; El-Fakhri G; Grinspoon SK
    J Infect Dis; 2017 Apr; 215(8):1264-1269. PubMed ID: 28204544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of
    Unkart JT; Wallace AM
    J Nucl Med Technol; 2017 Sep; 45(3):181-184. PubMed ID: 28705929
    [No Abstract]   [Full Text] [Related]  

  • 13. Injection site radioactivity of (99m)Tc-labeled mannosylated dextran for sentinel lymph node mapping.
    Yamaguchi A; Hanaoka H; Pirmettis I; Uehara T; Tsushima Y; Papadopoulos M; Arano Y
    Mol Pharm; 2015 Feb; 12(2):514-9. PubMed ID: 25423619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A receptor-binding radiopharmaceutical for imaging of traumatic brain injury in a rodent model: [
    Chen W; Barback CV; Wang S; Hoh CK; Chang EY; Hall DJ; Head BP; Vera DR
    Nucl Med Biol; 2021 Jan; 92():107-114. PubMed ID: 32169304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Within-patient comparison between [
    Mahieu R; Donders DNV; Krijger GC; Ververs FFT; de Roos R; Bemelmans JLMM; van Rooij R; de Bree R; de Keizer B
    Eur J Nucl Med Mol Imaging; 2022 May; 49(6):2023-2036. PubMed ID: 34962582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoscintigraphy Using Tilmanocept Detects Multiple Sentinel Lymph Nodes in Melanoma Patients.
    Balkin DM; Tranah GJ; Wang F; O'Donoghue C; Morell EA; Porubsky C; Nosrati M; Vaquero EM; Kim H; Carr MJ; Montilla-Soler JL; Wu MC; Torre DM; Kashani-Sabet M; Zager JS; Leong SP
    Cancer Control; 2023; 30():10732748231153775. PubMed ID: 36705261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does
    Rietbergen DD; Pereira Arias-Bouda LM; van der Hage J; Valdés Olmos RA
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(5):275-280. PubMed ID: 34425967
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Murphy BL; Woodwick AR; Murphy KM; Chandler KJ; Johnson GB; Hunt CH; Peller P; Jakub JW; Homb AC
    J Nucl Med Technol; 2019 Dec; 47(4):300-304. PubMed ID: 31019032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A receptor-targeted fluorescent radiopharmaceutical for multireporter sentinel lymph node imaging.
    Emerson DK; Limmer KK; Hall DJ; Han SH; Eckelman WC; Kane CJ; Wallace AM; Vera DR
    Radiology; 2012 Oct; 265(1):186-93. PubMed ID: 22753678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tc-99m tilmanocept versus Tc-99m sulfur colloid in breast cancer sentinel lymph node identification: Results from a randomized, blinded clinical trial.
    Unkart JT; Hosseini A; Wallace AM
    J Surg Oncol; 2017 Dec; 116(7):819-823. PubMed ID: 28695567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.